Unleashing the Power of Competitive Intelligence in Oncology - Stay Ahead of the Game!
In today’s fiercely competitive pharmaceutical industry, staying ahead of the competition is crucial. Competitive intelligence (CI) has become an indispensable tool for companies seeking to gain a strategic advantage in oncology. CI involves collecting, analysing, and interpreting information about competitors, market trends, and industry developments, and translating it into actionable recommendations. By leveraging oncology competitive intelligence, pharmaceutical companies active in this space can make informed decisions, identify opportunities and threats, and develop effective strategies. At Solici, we offer a range of competitive intelligence services designed to help our clients stay ahead of the competition and achieve their business goals. Our team of experts has extensive oncology knowledge and expertise and can provide tailored insights and recommendations to help you make informed decisions. Our consultants have significant experience supporting development, launch and commercialisation of products in precision oncology,immuno-oncology, cell-based therapies such as CAR-T, as well as cancer biomarkers. We understand that each business and therapy area is unique and requires a customised approach, which is why we offer personalised solutions that are tailored to your specific needs.
Oncology Competitive Intelligence Deep-Dives
CI deep-dives are comprehensive assessments of the competitive landscape in oncology. They provide a detailed analysis of the market, competitors, and industry trends. At Solici, deep-dives are conducted by our expert oncology consultants who use their experience and various tools and techniques to gather and analyse data. The team then provides a detailed report that includes recommendations for product development, marketing, and sales strategies. CI deep-dives are especially useful for clients who need to understand a particular market segment in detail or want to gain an in-depth understanding of a competitor’s business model or product line. Our deep dive reports may include information on market trends, product features and pricing, competitive landscape, regulatory environment, and other factors relevant to your business.
Oncology Conference Coverage
Attending oncology conferences is a crucial part of staying up-to-date with the latest developments in this critical therapy area. Solici oncology consultants attend numerous global and regional oncology congresses every year and collect information shared in key presentations, posters, and discussions, as well as conduct multiple primary research interviews with key stakeholders. Major conferences includeAmerican Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), American Association for Cancer Research (AACR), San Antonio Breast Cancer Symposium (SABCS), International Conference on Malignant Lymphoma (ICML), European Hematology Association (EHA) and Annual Meeting of the Society for Immunotherapy of Cancer (SITC). The information gathered from these congresses, which may include updates on new products, emerging technologies, regulatory developments and other relevant topics, is then analysed, synthesized into reports or summaries and translated into actionable recommendations that are shared with internal stakeholders, such as product development teams, marketing teams, and senior management.
Strategic Workshops for Oncology Product and Strategy Development
Our strategic workshops are a collaborative approach to product and brand development which bring together cross-functional teams from different areas of the company, including marketing, sales, R&D, regulatory, market access, and medical affairs. The goal of these workshops is to develop a comprehensive strategy for a pharmaceutical product or brand that takes into account the competitive landscape, patient needs, and other factors that may impact the product’s success.
During a strategic workshop, participants work together to identify key opportunities and challenges facing the product or brand, and to develop a plan for addressing these issues. This may involve brainstorming sessions, SWOT analysis, competitive landscape analysis, and other activities designed to generate insights and ideas.
Every Solici workshop is tailored to individual clients, however, some common elements include competitive landscape analysis, patient need identification, messaging platform development and tactical planning for executing on the strategy.
Technical Landscape Analysis for Oncology Products
Our technical landscape services provide detailed analysis and insights on the technical aspects of your competitors’ products and services, including manufacturing, formulation, delivery, and testing. We analyse data from a range of sources, including patents, clinical trial data, and regulatory filings, to help you understand the technical landscape of your market and identify opportunities for innovation. Our technical landscape reports may include information on key patents, clinical trial results, and regulatory filings. This service is especially useful for clients who are developing new products or looking to improve existing ones.
Solici – Your Oncology Competitive Intelligence Partner
Competitive intelligence is an essential tool for companies seeking to gain a strategic advantage in the oncology market. By leveraging CI tools and techniques, companies can make informed decisions, identify opportunities and threats, and develop effective strategies. At Solici, we pride ourselves on our ability to provide actionable insights and recommendations that are tailored to each client’s specific needs. We understand that each business is unique and requires a customised approach. Whether you’re launching a new oncology product or looking to stay ahead of the competition in this fast-paced industry, we can help.
Case Study: Supporting the Launch Strategy for a New Oncology Product
Our oncology competitive intelligence services are designed to help pharmaceutical companies stay ahead of the competition and achieve strong market penetration for their new products. We recently worked with a pharmaceutical company to support the launch strategy for a new oncology product, and the results were impressive.
Our team at Solici conducted extensive research and analysis to identify potential competitors and evaluate their strengths and weaknesses in the market. We also analysed market trends, pricing, and regulatory environment to provide insights into the market potential for the new product. Based on our analysis, we recommended a targeted launch strategy that focused on specific patient populations and healthcare providers.
To support the launch strategy, we provided ongoing monitoring of competitor activity and market trends. We also provided conference coverage to keep our client informed of the latest developments and emerging trends in the industry. Our technical landscape services provided valuable insights into the technical aspects of competitors' products, allowing our client to identify potential areas for innovation.
As a result of our services, our client was able to successfully launch their new oncology product and achieve strong market penetration. Our insights and recommendations helped our client make informed decisions and stay ahead of the competition in this highly competitive field.
Unleash the Power of Competitive Intelligence in Oncology Today
"*" indicates required fields